MSD's COVID-19 Pill Molnupiravir Gains First Approval In UK
To Be Marketed As Lagevrio
The UK has seized the chance of being first to approve the oral COVID-19 drug, though details of how the treatment will be made available on the NHS are still being decided. • Source: Alamy
